Position
Chief Executive Officer
Company
TORL BioTherapeutics
Culver CityBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
TORL BioTherapeutics LLC has announced the appointment of Aran Maree, M.D., as Chief Executive Officer, effective May 1, 2026. Dr. Maree, who previously served as Chief Medical Officer, succeeds Mark Alles in this role.
Quick answer
TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer (May 7, 2026). TORL BioTherapeutics is based in Culver City, California, United States.
- Who is the new Chief Executive Officer at TORL BioTherapeutics?
- TORL BioTherapeutics named Aran Maree, M.D. Chief Executive Officer, announced May 7, 2026.
- What did TORL BioTherapeutics announce on May 7, 2026?
- TORL BioTherapeutics LLC has announced the appointment of Aran Maree, M.D., as Chief Executive Officer, effective May 1, 2026. Dr. Maree, who previously served as Chief Medical Officer, succeeds Mark Alles in this role.
- What does TORL BioTherapeutics do?
- TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer...
- Where is TORL BioTherapeutics based?
- TORL BioTherapeutics is based in Culver City, California, United States.
- Which similar companies made leadership changes around the same time?
- OnCusp Therapeutics (May 14, 2026), VistaGen (May 19, 2026), BridgeBio Oncology Therapeutics (April 22, 2026) and Retension Pharmaceuticals (May 27, 2026) also announced leadership changes within 45 days of TORL BioTherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer (May 14, 2026)
- Vistagen Appoints Angel S. Angelov as Chief Medical Officer (May 19, 2026)
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
Who to call at TORL BioTherapeutics, and when
A new leader at TORL BioTherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day TORL BioTherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TORL BioTherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TORL BioTherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TORL BioTherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TORL BioTherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.